Ion Beam Applications SA
Aurore Gillmann is an accomplished professional with extensive experience in enterprise applications, HR transformation, and financial management. Currently serving as the Head of Enterprise Applications at IBA since April 2024, Aurore leads a team of Business Analysts and manages vendor relationships to align digital solutions with business goals. Prior roles at D'Ieteren included Manager of HR Transformation & Shared Services, where Aurore implemented a new HR Shared Services organization, and Chief Financial Officer (ad-interim) at D'Ieteren Mobility Company, overseeing financial operations during a transitional phase. Aurore's career also includes founding the Transformation Office at D'Ieteren Auto, directing financial planning as Financial Controller, and supervising invoicing at CHU Brugmann. Aurore holds an Executive Master in Management from Solvay Brussels School, a Master in Labour Sciences from Université Libre de Bruxelles, and a Bachelor in Business Computing from Haute Ecole d'Enseignement Supérieur de Namur.
This person is not in any teams
This person is not in any offices
Ion Beam Applications SA
4 followers
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.